Patiromer Promising in Optimizing HF Treatments for Patients with Hyperkalemia, DIAMOND Trial Reveals Medha Baranwal27 Sept 2024 8:15 PM ISTUSA: Recent findings highlight the role of patiromer in improving treatment outcomes for patients with heart failure and hyperkalemia.The study,...
SGLT-2 inhibitors and MRAs combo reduces cardiovascular events in patients with CKD Jacinthlyn Sylvia23 Nov 2022 8:00 PM ISTA new study published in Diabetes Research and Clinical Practice suggests that combination of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and...
Mineralocorticoid Receptor Antagonists offer great economic value in HF patients: AHA/ACC/HFSA 2022. Dr. Prem Aggarwal28 April 2022 12:45 PM ISTMineralocorticoid Receptor Antagonists (MRA) have a great potential economic value to offer in patients with Heart Failure with mild ejection fraction...
Patiromer Improves Potassium Levels in CKD patients with HFrEF: DIAMOND Trial MD Bureau13 April 2022 9:30 AM ISTRenin-angiotensin-aldosterone system inhibitors (RAASi) are the cornerstone of treatment for both heart failure with reduced ejection fraction (HFrEF)...
Mineralocorticoid receptor antagonists improve outcomes in kidney failure patients on dialysis Medical Dialogues Editorial Team21 March 2022 9:00 AM ISTTaiwan: Mineralocorticoid receptor antagonists may enhance clinical outcomes in individuals with renal failure without increasing the risk of...
MRA Strongly Recommended in Treatment of Heart Failure with Reduced Ejection Fraction: 2021 ESC Guidelines Medical Dialogues Bureau17 Nov 2021 12:45 PM ISTPharmacotherapy is the cornerstone of treatment for Heart Failure with Reduced Ejection Fraction (HFrEF) and should be implemented before considering...
Relevance of post-MI use of beta-blockers and MRA, reveals new study Medha Baranwal20 July 2021 9:00 AM ISTUSA: The effects of beta-blocker therapy on survival after myocardial infarction (MI), when analyzed dichotomously, on (all doses) did not demonstrate...
Mineralocorticoid receptor antagonists improve clinical outcomes of kidney failure: Study Dr. Shravani Dali16 July 2021 9:00 AM ISTMineralocorticoid receptor antagonists may give better treatment outcomes of patients with kidney failure on dialysis without increasing the risk of...
Mineralocorticoid receptor antagonists beneficial for kidney failure patients: Study Medha Baranwal22 Jun 2021 9:00 AM ISTTaipei, Taiwan: The use of mineralocorticoid receptor antagonists may improve outcomes in kidney failure patients without causing an increase in...
